Upregulated MCL1 mRNA expression in multiple myeloma lacks association with survival: Correspondence

British Journal of Haematology

Volumn 144, Issue 6, 2009, Pages 961-963

  Mylin, Anne K ^a   Rasmussen, Thomas ^a   Lodahl, Marianne ^a   Dahl, Inger Marie ^b   Knudsen, Lene M ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Apoptosis; BCL2; BCL2L1; MCL1; Multiple myeloma

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 6; MESSENGER RNA; PROTEIN BCL 2; PROTEIN MCL 1;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; HUMAN; LETTER; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIAS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SURVIVAL RATE; UP-REGULATION;

EID: 60649107905     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07521.x     Document Type: Letter

References (10)

1. Derenne, S., Monia, B., Dean, N.M., Taylor, J.K., Rapp, M.J., Harousseau, J.L., Bataille, R. Amiot, M. (2002) Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells. Blood, 100, 194 199.
2. van de Donk, N.W., Lokhorst, H.M. Bloem, A.C. (2005) Growth factors and antiapoptotic signaling pathways in multiple myeloma. Leukemia, 19, 2177 2185.
3. Jourdan, M., De Vos, J., Mechti, N. Klein, B. (2000) Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1. Cell Death and Differentiation, 7, 1244 1252.
4. Le Gouill, S., Podar, K., Amiot, M., Hideshima, T., Chauhan, D., Ishitsuka, K., Kumar, S., Raje, N., Richardson, P.G., Harousseau, J.L. Anderson, K.C. (2004a) VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis. Blood, 104, 2886 2892.
5. Le Gouill, S., Podar, K., Harousseau, J.L. Anderson, K.C. (2004b) Mcl-1 regulation and its role in multiple myeloma. Cell Cycle, 3, 1259 1262.
6. Liu, Y., Hernandez, A.M., Shibata, D. Cortopassi, G.A. (1994) BCL2 translocation frequency rises with age in humans. Proceedings of the National Academy of Sciences of the United States of America, 91, 8910 8914.
7. Rasmussen, T., Jensen, L., Honore, L., Andersen, H. Johnsen, H.E. (1999) Circulating clonal cells in multiple myeloma do not express CD34 mRNA, as measured by single-cell and real-time RT-PCR assays. British Journal of Haematology, 107, 818 824.
8. Rasmussen, T., Theilgaard-Monch, K., Hudlebusch, H.R., Lodahl, M., Johnsen, H.E. Dahl, I.M. (2003) Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities. British Journal of Haematology, 123, 253 262.
9. Wuilleme-Toumi, S., Robillard, N., Gomez, P., Moreau, P., Le Gouill, S., Avet-Loiseau, H., Harousseau, J.L., Amiot, M. Bataille, R. (2005) Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival. Leukemia, 19, 1248 1252.
10. Zhang, B., Gojo, I. Fenton, R.G. (2002) Myeloid cell factor-1 is a critical survival factor for multiple myeloma. Blood, 99, 1885 1893.